BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors. 2011

Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Beijing Institute of Pharmacology and Toxicology, Beijing, China.

Based on the structure of HIV-1 gp41 binding site for small-molecule inhibitors, optimization of lead 2 resulted in the discovery of a new series of 2,5-dimethyl-3-(5-(N-phenylrhodaninyl)methylene)-N-(3-(1H-tetrazol-5-yl)phenyl)pyrrole compounds with improved anti-HIV-1 activity. The most active compounds 13a and 13j exhibited significant potency against gp41 6-HB formation with IC(50) values of 4.4 and 4.6 μM and against HIV-1 replication in the MT-2 cells with EC(50) values of 3.2 and 2.2 μM, respectively, thus providing a new starting point to develop highly potent small-molecule HIV fusion inhibitors targeting gp41.

UI MeSH Term Description Entries
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013777 Tetrazoles
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015700 HIV Envelope Protein gp41 Transmembrane envelope protein of the HUMAN IMMUNODEFICIENCY VIRUS which is encoded by the HIV env gene. It has a molecular weight of 41,000 and is glycosylated. The N-terminal part of gp41 is thought to be involved in CELL FUSION with the CD4 ANTIGENS of T4 LYMPHOCYTES, leading to syncytial formation. Gp41 is one of the most common HIV antigens detected by IMMUNOBLOTTING. Envelope Protein gp41, HIV,HIV Transmembrane Protein gp41,HTLV-III gp41,env Protein gp41, HIV,gp41(HIV),gp41 Envelope Protein, HIV
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Design, synthesis and biological evaluation of N-(3-(1H-tetrazol-1-yl)phenyl)isonicotinamide derivatives as novel xanthine oxidase inhibitors.
December 2019, European journal of medicinal chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
January 2020, Bioorganic chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Design, synthesis and biological evaluation of N-(4-alkoxy-3-(1H-tetrazol-1-yl)phenyl) heterocyclic aromatic amide derivatives as xanthine oxidase inhibitors.
October 2022, Bioorganic chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Synthesis and biological evaluation of some N-(3-(1H-tetrazol-5-yl) phenyl)acetamide derivatives as novel non-carboxylic PTP1B inhibitors designed through bioisosteric modulation.
October 2018, Bioorganic chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.
November 2011, Bioorganic & medicinal chemistry letters,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41.
January 2011, Journal of medicinal chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Design, synthesis and biological evaluation of novel 5-((substituted quinolin-3-yl/1-naphthyl) methylene)-3-substituted imidazolidin-2,4-dione as HIV-1 fusion inhibitors.
June 2020, Bioorganic chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.
November 2014, Bioorganic & medicinal chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Synthesis, Biological Evaluation, and 3D-QSAR Studies of N-(Substituted pyridine-4-yl)-1-(substituted phenyl)-5-trifluoromethyl-1H-pyrazole-4-carboxamide Derivatives as Potential Succinate Dehydrogenase Inhibitors.
February 2021, Journal of agricultural and food chemistry,
Xiao-Yang He, and Peng Zou, and Jiayin Qiu, and Ling Hou, and Shibo Jiang, and Shuwen Liu, and Lan Xie
Design, synthesis and evaluation of 1-(1,5-bis(4-substituted phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors with potential antidepressant action.
February 2023, RSC medicinal chemistry,
Copied contents to your clipboard!